SciELO - Scientific Electronic Library Online

 
vol.79 número6Prevalencia de trastornos depresivos e impedimento asociado en adolescentes de sexo femeninoPericarditis purulenta primaria por Streptococcus pneumoniae, a propósito de un caso clínico índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista chilena de pediatría

versión impresa ISSN 0370-4106

Resumen

TRINCADO M, ARTURO et al. Retinoblastoma in children, experience at a pediatric hospital. Rev. chil. pediatr. [online]. 2008, vol.79, n.6, pp.614-622. ISSN 0370-4106.  http://dx.doi.org/10.4067/S0370-41062008000600006.

Methods: Retrospective analysis of clinical charts of 41 children (59 eyes) diagnosed with retinoblastoma and treated by a multidisciplinary team at Hospital Luis Calvo Mackenna in Santiago-Chile, between 1999 and 2007. The information included gender, laterality, diagnosis age, presenting signs, tumor spread, treatment modality and survival rate. Results: A total of 23 cases (56%) were unilateral and 18 cases (44%) were bilateral. The mean age at diagnosis was 21.6 months (range 2 - 84) and 27 children (65.9%) were male. The most common presenting signs were leucokoria (51.2%), strabismus (24.4%) and proptosis (4.9%). Enucleation was performed in 48 eyes (81.3%), being the only required treatment in 17 children (41.5%). The remaining 24 patients received systemic and/or local therapy with chemotherapy, focal therapy and external beam radiation. 5 children died during the follow - up study period, due to extraocular extensión to the orbit, central nervous system and bone marrow. Conclusión: In spite of high enucleation rate as initial therapy for retinoblastoma, the survival rate with this current treatment protocol is similar to those from developed countries.

Palabras clave : Retinoblastoma; treatment; chemotherapy.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons